Effects Of Otago Exercise Versus Multisensory Integration Training On Balance And Gait In Elderly With Diabetes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-75
SponsorCairo University

About this trial

The goal of this clinical trial is to compare the effect of the Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus.

The main question it aims to answer is:

• Is there a significant difference between the effect of Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus? Researchers will compare Otago exercise to Multisensory integration training to know which one has the greatest benefit on balance \&gait in the elderly with type2 diabetes.

Participants will be divided into 3 groups; each group takes a certain training program for 8 weeks:

* First group: Otago exercise group plus conventional treatment for neuropathy. * Second group: Multisensory integration training group plus conventional treatment for neuropathy. * Third group: control group takes only conventional treatment for neuropathy.

Eligibility criteria

Qualifiers

Ninety elderly Patients of both genders.

Their age will range from 65 to 75th.

They will be diagnosed with type 2 diabetes for 5 years or more.

Patients with mild & moderate neuropathy will be included. (Based on the Toronto scale: -mild (6-8); moderate (9-11)

Disqualifiers

Any musculoskeletal disorder affecting the lower limb (fracture of the lower limb, tumors, any infection, ligament injuries, foot injuries).

Any other neurological disorder influences gait such as (stroke, Parkinson's disease, cerebellar dysfunction, ataxia, vestibular disorders)

Any other cardiovascular disease (arrhythmia, cardiac pacemakers).

Unstable proliferative retinopathy and visual impairments without correction.

Trial design

Treatments tested in this trial

  • Otago exercise
  • Multisensory integration training
  • conventional treatment for neuropathy

Treatment groups

90 Participants
are divided into 3 treatment groups

Sponsors and collaborators